New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
09:02 EDTBIOLOracle Partners announces favorable litigation against Biolase
Oracle Partners, Biolase's largest shareholder, announced that it has won a significant victory in its shareholder litigation against Biolase. Larry Feinberg, the Managing Member of Oracle's general partner stated: "Oracle Partners welcomes the decision of Vice Chancellor Noble of the Court of Chancery of the State of Delaware confirming the appointment of Paul Clark as a director of Biolase." The Court concluded that " the current directors of Biolase are the Undisputed Directors and Clark, who was appointed during the Meeting to the vacancy that had been created when Arrow verbally and effectively resigned; the Biolase board has one vacancy that was created when Low resigned by email after the Meeting; and Oracle is not liable to Biolase for fraud or negligent misrepresentation."
News For BIOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
16:51 EDTBIOLBIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO
BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use